Comparative Safety of Originator and Biosimilar Epoetin Alfa Drugs: An Observational Prospective Multicenter Study

BACKGROUND: Erythropoiesis-stimulating agents (ESAs) are biological molecules approved for the treatment of anemia associated with chronic renal failure. Biosimilars were licensed for use in Europe in 2007. AIM: This study aimed to compare the safety profile of biosimilars with respect to the refere...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BioDrugs
Main Authors: Stoppa, Giovanna, D’Amore, Carmen, Conforti, Anita, Traversa, Giuseppe, Venegoni, Mauro, Taglialatela, Maurizio, Leone, Roberto
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2018
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6061296/
https://ncbi.nlm.nih.gov/pubmed/30030767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0293-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados